We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Verdezyne Signs R&D Agreement for Novel Enzymes Gene Development with Syngenta
News

Verdezyne Signs R&D Agreement for Novel Enzymes Gene Development with Syngenta

Verdezyne Signs R&D Agreement for Novel Enzymes Gene Development with Syngenta
News

Verdezyne Signs R&D Agreement for Novel Enzymes Gene Development with Syngenta

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Verdezyne Signs R&D Agreement for Novel Enzymes Gene Development with Syngenta"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Verdezyne, Inc. has announced it has signed an agreement with Syngenta Biotechnology, Inc. Under the terms of the agreement, Verdezyne will synthesize novel genes, to be tested for optimized expression of enzymes in plants by Syngenta, using its technology platform.

“We are enthusiastic about applying Verdezyne’s technology platform for a leading agribusiness company,” said E. William Radany, Ph.D., President and Chief Executive Officer, Verdezyne. “This relationship is yet another example of the unique power of Verdezyne’s core technology to optimize the expression of key enzymes for the biotechnology marketplace.”

Verdezyne employs its biological expertise and proprietary advanced computational algorithms to design and synthesize novel gene libraries for engineering proteins, metabolic pathways, and microorganisms to manufacture platform chemicals and biofuels.

Financial details of the agreement were not disclosed.
Advertisement